dc.creatorVega Blanco, María Margarita
dc.creatorDevoto, Luigi
dc.creatorCastro, Olga
dc.creatorKohen Skop, Paulina
dc.date.accessioned2019-01-29T14:53:05Z
dc.date.available2019-01-29T14:53:05Z
dc.date.created2019-01-29T14:53:05Z
dc.date.issued1994
dc.identifierJournal of Clinical Endocrinology and Metabolism, Volumen 79, Issue 2, 2018, Pages 466-469
dc.identifier0021972X
dc.identifier10.1210/jc.79.2.466
dc.identifierhttps://repositorio.uchile.cl/handle/2250/161192
dc.description.abstractTo assess the role of estradiol (E2) upon progesterone (P4) synthesis, a well defined human midluteal cell system was used. A dose-dependent inhibition of P4 synthesis with and without hCG was induced by E2. In addition, E2 had a dose related cumulative effect on pregnenolone as compared with control experiments (2-fold, P < 0.05) as well as in hCG- stimulated conditions (3-fold, P < 0.005). On the other hand, the concentrations of 20α-hydroxyprogesterone obtained in all experimental conditions were similar to control values, indicating that the catabolism of P4 was not modified. 3β-Hydroxysteroid dehydrogenase activity was significantly diminished (P < 0.05) in the presence of E2. Finally, the kinetic studies on P4 synthesis from pregnenolone showed a competitive type of inhibition with a K1 of 2.22 x 10-6 mol/L. These data indicate an inhibition of 3β-hydroxysteroid dehydrogenase on human corpus luteum by E2.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Clinical Endocrinology and Metabolism
dc.subjectEndocrinology, Diabetes and Metabolism
dc.subjectBiochemistry
dc.subjectEndocrinology
dc.subjectClinical Biochemistry
dc.subjectBiochemistry (medical)
dc.titleProgesterone synthesis by human luteal cells: Modulation by estradiol
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución